Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients

被引：0
|
作者：
Federici, Augusto B. [1 ]
Iorio, Alfonso [2 ]
Castaman, Giancarlo [3 ]
机构：
[1] Univ Milan, Dept Internal Med, Milan, Italy
[2] Univ Perugia, I-06100 Perugia, Italy
[3] San Bortolo Hosp, Div Hematol, Vicenza, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：110 / 111
页数：2
相关论文
共 19 条
  • [1] Biologic response to desmopressin (DDAVP) in 8 type 2 von Willebrand disease (vWD) patients
    Windyga, J.
    Bykowska, K.
    Baran, B.
    Stefanska, E.
    [J]. HAEMOPHILIA, 2008, 14 : 118 - 118
  • [2] Clinical efficacy and safety of DDAVP with or without tranexamic acid in inherited VWD: final results of the prospective and international study on 229 patients
    Federici, A. B.
    Castaman, G.
    Iorio, A.
    Bonduel, M.
    D'Amico, E. A.
    Oliovecchio, E.
    Santoro, C.
    Siboni, S. M.
    Zieger, B.
    Mannucci, P. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 359 - 360
  • [3] Defining DDAVP responses in types 1 and 2 von Willebrand disease (VWD): a EUROPEAN survey
    Windyga, J.
    Dolan, G.
    Altisent, C.
    Katsarou, O.
    Lopez-Fernandez, M. -F.
    Zulfikar, B.
    [J]. HAEMOPHILIA, 2014, 20 : 65 - 66
  • [4] Biological response to desmopressin (DDAVP) in patients with von Willebrand disease: effect of age, sex and ABO group
    Kadir, R.
    Shiltagh, N.
    Tuddenham, E.
    [J]. HAEMOPHILIA, 2008, 14 : 114 - 114
  • [5] Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD
    Castaman, Giancarlo
    Lethagen, Stefan
    Federici, Augusto B.
    Tosetto, Alberto
    Goodeve, Anne
    Budde, Ulrich
    Batlle, Javier
    Meyer, Dominique
    Mazurier, Claudine
    Fressinaud, Edith
    Goudemand, Jenny
    Eikenboom, Jeroen
    Schneppenheim, Reinhard
    Ingerslev, Jorgen
    Vorlova, Zdena
    Habart, David
    Holmberg, Lars
    Pasi, John
    Hill, Frank
    Peake, Ian
    Rodeghiero, Francesco
    [J]. BLOOD, 2008, 111 (07) : 3531 - 3539
  • [6] Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history
    Sanchez Luceros, Analia
    Meschengieser, Susana S.
    Woods, Adriana I.
    Chuit, Roberto
    Turdo, Karina
    Blanco, Alicia
    Lazzari, Maria A.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2010, 104 (05) : 984 - 989
  • [7] Clinical Study to Investigate the Efficacy and Safety of Wilate during Prophylaxis in Previously Treated Patients with Von Willebrand Disease (VWD)
    Sidonio, Robert F., Jr.
    Schwartz, Bruce A.
    [J]. BLOOD, 2019, 134
  • [8] EFFICACY AND SAFETY OF HFVIII/VWF CONCENTRATE IN A COHORT OF PATIENTS WITH VON WILLEBRAND DISEASE (VWD) REQUIRING PROPHYLAXIS REGIMEN (OPALE STUDY)
    Rugeri, L.
    Trossaert, M.
    Harroche, A.
    d'Oiron, R.
    Borel-derlon, A.
    Desprez, D.
    Catovic, H.
    Bracquart, D.
    [J]. HAEMOPHILIA, 2020, 26 : 139 - 139
  • [9] Regular Replacement Therapy as Prophylaxis In Severe Forms of Von Willebrand Disease: Initial Results From the Von Willebrand Disease Prophylaxis Network (VWD PN) Study Group
    Berntorp, Erik
    Abshire, Thomas C.
    Federici, Augusto B.
    [J]. BLOOD, 2010, 116 (21) : 109 - 110
  • [10] CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF A VON WILLEBRAND FACTOR FVIII CONCENTRATE (VWF/FVIII) DURING PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH VON WILLEBRAND DISEASE (VWD)
    Sidonio, R.
    Dubey, L.
    Timofeeva, M.
    Vilchevska, K.
    Vdovin, V.
    Schmid, M.
    Solomon, C.
    Knaub, S.
    [J]. HAEMOPHILIA, 2020, 26 : 140 - 140
12